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Abstract
Chapter 1 Overview of orphan receptor TR3
 
The immediate-early gene product TR3 (also known as Nur77 or NGFI-B) is a
nuclear receptor of the steroid/thyroid/retinoid receptor superfamily. Since its
physiological ligand has not been identified, TR3 is also termed as orphan
receptor. The expression of TR3 can be immediately induced by many growth
factors and pro-apoptotic factors. As a transcriptional factor, TR3 regulates the
transcription of many genes through binding to its response element, therefore
playing important roles in cell proliferation, apoptosis, metabolism and
inflammatory reaction. In addition, the subcellular localization of TR3 is also
important for its biological functions. When translocation from the nucleus to the
mitochondria, TR3 interacts with Bcl-2 and converts Bcl-2 from a cytoprotective to
a cytodestructive protein to trigger apoptosis. Moreover, TR3 can also regulate
the function of other proteins through protein-protein interaction. Therefore, in this
chapter, we provide an overview of TR3, and demonstrate that after complicated






Chapter 2.  Akt phosphorylates TR3 and blocks
its mitochondrial targeting
 













in processes such as metabolism, apoptosis, and proliferation. However, the
precise mechanisms by which Akt promotes cell survival and inhibits apoptosis
have been characterized in part only. TR3, an orphan receptor, functions as a
transcription factor that can both positively or negatively regulate gene
expression. We have previously reported that the translocation of TR3 from the
nucleus to the mitochondria can elicit a proapoptotic effect in gastric cancer cells.
In our present study, we demonstrate that Akt phosphorylates cytoplasmic TR3
through its physical interaction with the N-terminus of TR3. When co-expressed
with Akt, TR3 mitochondrial targeting was blocked and this protein adopted a
diffuse expression pattern in the cytoplasm. Moreover, Akt displayed an ability to
disrupt the interaction of TR3 with Bcl-2, which is thought to be a critical
requirement for mitochondrial TR3 to elicit apoptosis. Consistently, insulin was
also found to induce the phosphorylation of TR3 and abolish TPA-induced
mitochondrial localization, which was dependent upon the activation of the PI3K-
Akt signaling pathway. Taken together, our current data demonstrate a unique
role for Akt in inhibiting TR3 functions that are not related to transcriptional activity
but that correlate with the regulation of its mitochondrial association. This may
represent a novel signal pathway by which Akt exerts its anti-apoptotic effects in






Chapter 3.  Isomerization of TR3 by Pin1 plays a dual role
in cell proliferation and apoptosis
 













post-phosphorylation mechanisms. In our current study, we characterize TR3 as a
novel Pin1 substrate. We show that (1) phosphorylation of TR3 by ERK facilitates
the recognition and binding of Pin1; (2) TR3 Ser95 residue is the key site through
which Pin1 enhances TR3 stability by inhibiting its degradation; and (3) the
isomerization of Ser431-Pro motif in TR3 by Pin1 results in the activation of TR3
by enhancing its DNA binding affinity. Furthermore, we find that Pin1 not only
enhances TR3 targeting to the promoter of cyclin D2, which is a novel
downstream of TR3, but also promotes the TR3 recruitment of p300, ultimately
resulting in increased cell proliferation. On the other hand, Pin1 is found also to
assist TR3 nuclear export and mitochondrial targeting in response to TPA,
thereby initiating cellular apoptosis. The regulatory role of Pin1 in the TR3
pathways is further confirmed by an in vivo tumor formation assay. Our current
study thus demonstrates that Pin1 plays a dual role in cell proliferation and





Chapter 4.  Molecular mechanism of TR3 in negative regulation of Wnt signaling
pathway
 
Wnt signaling controls various cell fates, including development, proliferation and
tumorigenesis. Binding of Wnt ligand to its transmembrane receptors inhibits
phosphorylation and degradation of the transcriptional coactivator β-Catenin,
which then results in the translocation of β-Catenin from the cytoplasm to the
nucleus to regulate the expression of target genes. Our previous study has
indicated that TR3 serves as a transcriptional repressor to inhibit the activities of













signaling, either physiologically by Wnt ligands or pathologically by APC
inactivation or β-catenin activation. Although TR3 does not show any influences
on the expression levels of β-Catenin, the interaction between TR3 and β-Catenin
disrupts the β-Catenin DNA binding, thereby inhibiting the expression of Wnt
downstream proteins, such as c-myc and cyclin D1. In addition, Axin and GSK3β,
negative regulators of Wnt signaling, cooperate with TR3 to repress the activity of
Wnt signal. Moreover, in nude mice xenograft experiment, we also confirmed that
Csn-B, a specific TR3 agonist, represses tumor growth in a TR3-dependent
fashion. Taken together, our study demonstrates a novel function of TR3 as a
tumor suppressor to inhibit the Wnt signaling pathway.
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